跳至主要内容
临床试验/NCT03348371
NCT03348371已完成不适用

The Effects of Orally Ethanol vs. Isoethanolaemic i.v. Infusion of Ethanol on Intestinal Permeability and Gut Hormones

University of Copenhagen0 个研究点目标入组 12 人开始时间: 2016年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
12
主要终点
Serum insulin level

研究概览

简要总结

The aime of this study is to envsitigate if ethanol has an incretin effect. This is done by administration of ethanol orally vs. an isoethanolaemic i.v. infusion of ethanol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Caucasian male between 20 and 50 years of age
  • •Body mass index (BMI) between 19 and 25 kg/m2
  • •Weekly alcohol intake of less than 14 units of alcohol (of 12 g)
  • •Normal fasting plasma glucose concentration (i.e. <6 mmol/l) and normal glycated haemoglobin A1c (HbA1c) (i.e. ≤42 mmol/mol)
  • •Normal haemoglobin
  • •Informed consent

排除标准

  • •First-degree relatives with diabetes and/or liver disease
  • •Liver disease or other alcohol-related diseases, diabetes mellitus
  • •Liver disease (serum ALAT and/or serum ASAT >2 × normal values)
  • •Nephropathy (serum creatinine above normal range and/or albuminuria)

研究组 & 干预措施

i.v. infusion day

Experimental

Participant receive ethanol in an i.v. infusion

干预措施: Ethanol (Other)

Oral day

Experimental

Participant receive ethanol orally

干预措施: Ethanol (Other)

结局指标

主要结局

Serum insulin level

时间窗: 2 month

difference in serum insulin level between the two administration forms

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amalie Lanng

BA

University of Copenhagen

相似试验